We are live on ! Find out more
HLTH

Cue Health Inc. Common Stock

Delisted

HLTH was delisted on the 5th of June, 2024.

63 hedge funds and large institutions have $9.83M invested in Cue Health Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,250% more call options, than puts

Call options by funds: $87K | Put options by funds: $2K

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

13% less funds holding

Funds holding: 7263 (-9)

50% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 14

57% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 21

66% less capital invested

Capital invested by funds: $28.6M → $9.83M (-$18.8M)

Holders
63
Holders Change
-9
Holders Change %
-12.5%
% of All Funds
0.92%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
7
Increased
9
Reduced
21
Closed
14
Calls
$87K
Puts
$2K
Net Calls
+$85K
Net Calls Change
-$142K
Name Holding Trade Value Shares
Change
Change in
Stake
TC
1
Tarsadia Capital
New York
$1.74M
OC
2
Oakmont Corp
California
$1.56M
DC
3
Decheng Capital
California
$1.46M +$2.98M +8,980,909 New
MA
4
Madrone Advisors
California
$1.15M
JPC
5
Jabodon PT Co
Nevada
$647K
Goldman Sachs
6
Goldman Sachs
New York
$638K +$1.29M +3,895,774 +12,520%
Vanguard Group
7
Vanguard Group
Pennsylvania
$631K
Temasek Holdings
8
Temasek Holdings
Singapore
$508K
BlackRock
9
BlackRock
New York
$256K -$22K -66,404 -4%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$169K +$4.59K +13,817 +1%
BL
11
Bleichroeder LP
New York
$163K
Jacobs Levy Equity Management
12
Jacobs Levy Equity Management
New Jersey
$153K -$62.1K -187,217 -17%
Verition Fund Management
13
Verition Fund Management
Connecticut
$140K -$4.21K -12,700 -1%
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$77.5K -$64.3K -193,684 -29%
Renaissance Technologies
15
Renaissance Technologies
New York
$76K +$47.4K +142,800 +44%
MP
16
MSD Partners
New York
$64.2K
State Street
17
State Street
Massachusetts
$53.8K
BRWA
18
B. Riley Wealth Advisors
Florida
$52.6K +$21.2K +64,000 +25%
KI
19
Koch Industries
Kansas
$40.9K -$649K -1,956,051 -89%
Millennium Management
20
Millennium Management
New York
$40.7K -$36.9K -111,267 -31%
Invesco
21
Invesco
Georgia
$38.5K +$22 +65 +0%
Northern Trust
22
Northern Trust
Illinois
$27.6K
Two Sigma Advisers
23
Two Sigma Advisers
New York
$23K -$28.7K -86,500 -38%
Jane Street
24
Jane Street
New York
$19K +$29.3K +88,165 +305%
Capstone Investment Advisors
25
Capstone Investment Advisors
New York
$15K

HLTH Hedge Fund Activity: Q4 2023 in Review

63 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Cue Health Inc. Common Stock (HLTH) for Q4 2023, worth a combined $9.83M — down 66% from $28.6M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of HLTH and 7 opened new positions — a net loss of 7 holders — while 21 trimmed existing stakes and 9 added.

The largest buyer was Goldman Sachs, adding an estimated $1.29M. The largest seller was Johnson & Johnson, exiting entirely with an estimated $2.45M sold.

  • 63 institutional investors held Cue Health Inc. Common Stock (HLTH) as of Q4 2023, down from 72 in Q3 2023.
  • Funds reported $9.83M of Cue Health Inc. Common Stock stock for Q4 2023, down 66% quarter-over-quarter.
  • 7 funds opened new Cue Health Inc. Common Stock positions in Q4 2023 and 14 closed out, a net change of -7 holders.
  • The largest Cue Health Inc. Common Stock buyer in Q4 2023 was Goldman Sachs, an estimated $1.29M added.
  • The largest Cue Health Inc. Common Stock seller in Q4 2023 was Johnson & Johnson, an estimated $2.45M sold.

Based on aggregated 13F filings for Q4 2023.